Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumin Yoon

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biopharmaceutics & Drug Disposition|March 29, 2019
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulationYun Kim, Oliver Hatley, Su-Jin Rhee, et al.
ACS Applied Materials & Interfaces|September 19, 2025
Improvements in Mechano-Electrochemical Energy Harvesting Performance of Carbon Nanotube Yarns via Poly(sodium 4-styrenesulfonate) CoatingGyu Hyeon Song, Jong Woo Park, Ji Hwan Moon, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
Sumin Yoon, Su-Jin Rhee, Sang-In Park, et al.
The Gerontologist|April 2, 2026
What makes caregiving difficult according to Reddit usersKenneth Lam, Sumin Yoon, Annika Rhea Bhananker, et al.
Cancer Communications (London, England)|July 27, 2025
Coordinated gene expression within sustained STAT3-associated chromatin conformations contributes to hepatocellular carcinoma progressionSunyoung Jang, Sumin Yoon, Hyeokjun Yang, et al.
Journal of Korean Medical Science|January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal ImpairmentAndrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjectsSoyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
Cancer Communications (London, England)|July 29, 2024
Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesisDae-Hwan Kim, Minjeong Sung, Myong-Suk Park, et al.
International Journal of Molecular Sciences|November 9, 2024
<i>NRXN1</i> as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon CancerHyun Jin Bang, Hyun-Jeong Shim, Mi-Ra Park, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biopharmaceutics & Drug Disposition|March 29, 2019
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulationYun Kim, Oliver Hatley, Su-Jin Rhee, et al.
ACS Applied Materials & Interfaces|September 19, 2025
Improvements in Mechano-Electrochemical Energy Harvesting Performance of Carbon Nanotube Yarns via Poly(sodium 4-styrenesulfonate) CoatingGyu Hyeon Song, Jong Woo Park, Ji Hwan Moon, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
Sumin Yoon, Su-Jin Rhee, Sang-In Park, et al.
The Gerontologist|April 2, 2026
What makes caregiving difficult according to Reddit usersKenneth Lam, Sumin Yoon, Annika Rhea Bhananker, et al.
Cancer Communications (London, England)|July 27, 2025
Coordinated gene expression within sustained STAT3-associated chromatin conformations contributes to hepatocellular carcinoma progressionSunyoung Jang, Sumin Yoon, Hyeokjun Yang, et al.
Journal of Korean Medical Science|January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal ImpairmentAndrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjectsSoyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
Cancer Communications (London, England)|July 29, 2024
Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesisDae-Hwan Kim, Minjeong Sung, Myong-Suk Park, et al.
International Journal of Molecular Sciences|November 9, 2024
<i>NRXN1</i> as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon CancerHyun Jin Bang, Hyun-Jeong Shim, Mi-Ra Park, et al.
Pageof 4